CIK 0000874015
- Large accelerated filer
IONIS PHARMACEUTICALS INC
Sign in to watch- Ticker
- IONS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- CA
- Entity type
- Operating
- EIN
- 330336973
- Phone
- +1 760-931-9200
- Business address
- 2855 GAZELLE COURT, CARLSBAD, CA, 92010
- Former names
- ISIS PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $148,200
- in 1 filing
- Open-market sales, last 90 days
- $61,389
- in 2 filings
Net +$86,811. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-04-15 | Baroldi Joseph EVP, Chief Business Officer | Option exercise · Restricted Stock Unit | −10,837 | 66,511 | ||
| 2025-03-11 | Monia Brett P Chief Executive Officer | Sale 10b5-1 | −140 | $32.32 | $5K | 180,980 |
| 2025-02-28 | Swayze Eric EVP Research | Other acquisition | +415 | $28.21 | $12K | 48,432 |
| 2025-02-28 | O'NEIL PATRICK R. EVP CLO & General Counsel | Other acquisition | +554 | $28.21 | $16K | 56,799 |
| 2025-02-28 | Monia Brett P Chief Executive Officer | Other acquisition | +437 | $28.21 | $12K | 181,120 |
| 2025-02-28 | Geary Richard S EVP, Chief Development Officer | Other acquisition | +415 | $28.21 | $12K | 99,492 |
| 2025-02-28 | Birchler Brian EVP, Corp and Development Ops | Other acquisition | +414 | $28.21 | $12K | 55,465 |
| 2025-02-28 | BENNETT C FRANK EVP, Chief Scientific Officer | Other acquisition | +320 | $28.21 | $9K | 93,466 |
| 2025-02-20 | O'NEIL PATRICK R. EVP CLO & General Counsel | Sale 10b5-1 | −1,207 | $32.35 | $39K | 56,245 |
| 2025-02-04 | O'NEIL PATRICK R. EVP CLO & General Counsel | Sale 10b5-1 | −6,165 | $31.62 | $195K | 57,452 |
| 2025-02-04 | Monia Brett P Chief Executive Officer | Sale 10b5-1 | −38,843 | $31.65 | $1.2M | 180,683 |
| 2025-01-31 | Swayze Eric EVP Research | Sale | −1,367 | $32.31 | $44K | 48,017 |
| 2025-01-31 | Schneider Eugene EVP, Chf Clinical Develop Ofcr | Sale | −1,484 | $32.20 | $48K | 61,056 |
| 2025-01-31 | O'NEIL PATRICK R. EVP CLO & General Counsel | Sale | −1,406 | $32.49 | $46K | 63,617 |
| 2025-01-31 | Monia Brett P Chief Executive Officer | Sale | −13,242 | $32.45 | $430K | 219,526 |
| 2025-01-31 | HOUGEN ELIZABETH L EVP, Finance & CFO | Sale | −1,523 | $32.44 | $49K | 110,500 |
| 2025-01-31 | Geary Richard S EVP, Chief Development Officer | Sale | −1,406 | $32.40 | $46K | 99,077 |
| 2025-01-31 | BENNETT C FRANK EVP, Chief Scientific Officer | Sale | −1,327 | $32.46 | $43K | 93,146 |
| 2025-01-30 | Swayze Eric EVP Research | Grant or award | +3,714 | 49,384 | ||
| 2025-01-30 | Schneider Eugene EVP, Chf Clinical Develop Ofcr | Grant or award | +4,032 | 62,540 |
Page 31 of 34 · 668 trades